TENAX THERAPEUTICS, INC.
TENX · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
ADAR1 Capital Management, LLC: Form 4
Insider disclosure · Filed · Report period 19 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0000034956 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- TENX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 101 Glen Lennox Drive, Suite 300, Chapel Hill, NC, 27517
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- OXYGEN BIOTHERAPEUTICS, INC. (to 15 Sep 2014), SYNTHETIC BLOOD INTERNATIONAL INC (to 30 Jun 2008)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields